| Primary |
| Asthma |
29.5% |
| Pharyngitis |
22.7% |
| Nasopharyngitis |
18.2% |
| Dyspnoea |
13.6% |
| Back Pain |
4.5% |
| Eczema |
4.5% |
| Gastritis Prophylaxis |
4.5% |
| Asthmatic |
2.3% |
|
| Cardio-respiratory Arrest |
28.6% |
| Drug Exposure During Pregnancy |
28.6% |
| Pyrexia |
28.6% |
| Tremor |
14.3% |
|
| Secondary |
| Product Used For Unknown Indication |
30.0% |
| Asthma |
19.0% |
| Drug Use For Unknown Indication |
13.2% |
| Chronic Obstructive Pulmonary Disease |
9.2% |
| Hypertension |
4.1% |
| Osteoporosis |
3.6% |
| Atrial Fibrillation |
2.5% |
| Prophylaxis |
2.4% |
| Pneumonia |
1.9% |
| Sedation |
1.7% |
| Bronchitis |
1.5% |
| Bronchospasm |
1.5% |
| Cardiac Disorder |
1.4% |
| Infection |
1.2% |
| Lung Infection |
1.2% |
| Alcohol Withdrawal Syndrome |
1.1% |
| Anxiety |
1.1% |
| Nasopharyngitis |
1.1% |
| Asthmatic Crisis |
1.0% |
| Coronary Artery Disease |
1.0% |
|
| Thrombocytopenia |
11.2% |
| Rash Erythematous |
9.0% |
| Drug Ineffective |
7.9% |
| Drug Exposure During Pregnancy |
6.7% |
| Insomnia |
6.7% |
| Iron Deficiency Anaemia |
6.7% |
| Pyrexia |
4.5% |
| Squamous Cell Carcinoma |
4.5% |
| Toxic Epidermal Necrolysis |
4.5% |
| Transaminases Increased |
4.5% |
| Abdominal Pain Upper |
3.4% |
| Alveolitis Allergic |
3.4% |
| Ejection Fraction Decreased |
3.4% |
| Haematemesis |
3.4% |
| Lymphopenia |
3.4% |
| Metabolic Alkalosis |
3.4% |
| Pruritus |
3.4% |
| Pulmonary Hypertension |
3.4% |
| Tachycardia |
3.4% |
| Toxic Skin Eruption |
3.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.0% |
| Product Used For Unknown Indication |
21.7% |
| Asthma |
13.2% |
| Chronic Obstructive Pulmonary Disease |
5.5% |
| Pain |
4.6% |
| Hypertension |
4.1% |
| Prophylaxis |
3.3% |
| Rheumatoid Arthritis |
2.9% |
| Unevaluable Event |
2.5% |
| Premedication |
2.4% |
| Sedation |
1.8% |
| Constipation |
1.7% |
| Osteoporosis |
1.7% |
| Atrial Fibrillation |
1.6% |
| Hiv Infection |
1.6% |
| Depression |
1.5% |
| Epilepsy |
1.5% |
| Pneumonia |
1.5% |
| Ill-defined Disorder |
1.4% |
| Dyspnoea |
1.4% |
|
| Weight Increased |
9.0% |
| Vomiting |
8.7% |
| Asthma |
8.3% |
| Dyspnoea |
7.7% |
| Thrombocytopenia |
6.0% |
| Pneumonia |
5.3% |
| Urticaria |
5.3% |
| Pruritus |
4.7% |
| Pulmonary Embolism |
4.3% |
| Renal Failure Acute |
4.3% |
| Tachycardia |
4.3% |
| Hepatocellular Injury |
4.0% |
| Rhabdomyolysis |
4.0% |
| Tooth Fracture |
3.7% |
| Weight Decreased |
3.7% |
| Death |
3.3% |
| Nausea |
3.3% |
| Pyrexia |
3.3% |
| Respiratory Failure |
3.3% |
| Wheezing |
3.3% |
|
